Scanner I (n = 32) | Scanner II (n = 10) | p value | |
---|---|---|---|
Male gender | 23 (72) | 10 (100) | 0.001 |
Age (years) | 68.9 ± 8.5 | 56.1 ± 15.9 | 0.033 |
BMI (kg/m2) | 26.0 ± 3.7 | 24.5 ± 3.5 | 0.374 |
BSA (m2) | 1.90 ± 0.18 | 2.04 ± 0.17 | 0.044 |
Hypertension | 18 (56) | 3 (30) | 0.158 |
Diabetes | 6 (19) | 0 (0) | 0.012 |
NYHA class | |||
I | 19 (59) | 7 (70) | 0.556 |
II | 8 (25) | 2 (20) | 0.75 |
III | 4 (13) | 1 (10) | 0.833 |
Unknown | 1 (3) | 0 (0) | 0.325 |
LVEF (%) | 66 ± 11 | 60 ± 6 | 0.039 |
RF (%) | – | 41 ± 11 | – |
Medication | |||
ACE or ATII inhibitors | 9 (28) | 3 (30) | 0.915 |
Beta-blockers | 4 (13) | 2 (20) | 0.616 |
Statins | 20 (63) | 0 (0) | <0.001 |
Diuretics | 16 (50) | 0 (0) | <0.001 |
Calcium antagonists | 8 (25) | 1 (10) | 0.25 |